Fact CheckerSign in

NCT04962919Completed

Survival Outcomes in Metastatic Prostate Cancer in the Brazilian Population - Analysis of Individual Characteristics and Treatment Modalities in Different National Health Institutions.

Source: ClinicalTrials.gov · Last updated 2 Sept 2026

Brief summary (registry, in English)

Survival outcomes in metastatic prostate cancer in the population Brazilian - analysis of individual characteristics and modalities of treatment in different national health institutions

Status (registry)
Completed
Study type
Observational
Enrollment
584 (actual)
First submitted
24 Jun 2021
Start date
14 Jan 2020
Primary completion date
31 Jan 2024
Lead sponsor
Latin American Cooperative Oncology Group
NCT number
NCT04962919

What you commit to

  • Study type: Observational
  • Participants enrolled: 584
  • From 14 Jan 2020 to the primary completion date, 31 Jan 2024
  • 18 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Patients with medical records filled with incomplete data that make it impossible to evaluate the treatment received.

Other illness

  • Diagnosis of localized or locally advanced or metastatic disease sensitive to castration;

Who the study is looking for

  • Diagnosis of castration-resistant metastatic prostate cancer diagnosed in the period between January 2014 and December 2017.

Age in the registry: 18 years to - · Sex: Male · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (18)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Hospital Sírio-Libanês DF
Coordinator of this site? Confirm its status
BrasíliaBrazilUnknown status
Hospital de Base do IGESDF - Instituto de Gestão Estratégica em Saúde do Distrito Federal
Coordinator of this site? Confirm its status
BrasíliaBrazilUnknown status
Clínica Prognóstica - Centro de Pesquisa Clínica Onconeo
Coordinator of this site? Confirm its status
Campo GrandeBrazilUnknown status
UOPECCAN - Hospital do Câncer de Cascavel
Coordinator of this site? Confirm its status
CascavelBrazilUnknown status
Hospital Napoleão Laureano
Coordinator of this site? Confirm its status
João PessoaBrazilUnknown status
CPO Pucrs
Coordinator of this site? Confirm its status
Porto AlegreBrazilUnknown status
ISEP - Instituto Santa Joana de Ensino e Pesquisa (Rede Américas)
Coordinator of this site? Confirm its status
RecifeBrazilUnknown status
IMIP - Instituto de Medicina Integral Professor Fernando Figueira
Coordinator of this site? Confirm its status
RecifeBrazilUnknown status
Ética Pesquisa Clínica
Coordinator of this site? Confirm its status
SalvadorBrazilUnknown status
Centro de Estudos e Pesquisas de Hematologia e Oncologia- CEPHO
Coordinator of this site? Confirm its status
Santo AndréBrazilUnknown status
FUNFARME - Fundação Faculdade Regional de Medicina de São José do Rio Preto
Coordinator of this site? Confirm its status
São José do Rio PretoBrazilUnknown status
Hospital de Oncologia do Maranhão Dr. Tarquínio Lopes Filho
Coordinator of this site? Confirm its status
São LuísBrazilUnknown status
Centro Paulista de Oncologia
Coordinator of this site? Confirm its status
São PauloBrazilUnknown status
Hospital Santa Marcelina
Coordinator of this site? Confirm its status
São PauloBrazilUnknown status
Irmandade da Santa Casa de Misericórdia de São Paulo - Hospital Central
Coordinator of this site? Confirm its status
São PauloBrazilUnknown status
Sírio Libanês
Coordinator of this site? Confirm its status
São PauloBrazilUnknown status
BP - A Beneficência Portuguesa de São Paulo
Coordinator of this site? Confirm its status
São PauloBrazilUnknown status
A.C. Camargo Cancer Center
Coordinator of this site? Confirm its status
São PauloBrazilUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.